<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20200421047158N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2021-01-07</date_registration>
      <primary_sponsor>Islamic Azad University</primary_sponsor>
      <public_title>Exploring the effect of combined decongestive therapy and Pilates exercise on the reduction of lymphedema symptom</public_title>
      <acronym></acronym>
      <scientific_title>The effect of combined decongestive therapy with and without Pilates exercise on the expression of inflammatory biomarkers and body measurement in breast patients with upper extremity lymphedema</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2020-05-30</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>30</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/49532</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Not blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment, Randomization description: In present study, simple randomisation method is used. Using random number table, we selected first number randomly. If the selected number is between 0 and 5, we allocated the subject to intervention group (group A) and when the number is between 6 and 9, patients were allocated to control group (group B).This process was continued to recruit 30 patients.</study_design>
      <phase>N/A</phase>
      <hc_freetext>Breast cancer related Lymphedema.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group: The standard decongestant treatment method combined with selected pilates training was performed for 6 weeks and 5 days per week for 30-40 minutes. warm up exercises included 10 minutes of breathing exercises then the main movements were performed aiming at strengthening arm and shoulder muscles containing rest intervals, thus the exercises continued until fatigue which included 7 exercises in one to three sets for 20 minutes. At the end, stretching and body cooling exercises were performed for 5 minutes. Intervention 2: Control group: Patients in the control group received standard combined decongestive therapy involves manual drainage of lymph nodes which was performed daily (5 days a week) for 3 weeks for a total of 21 sessions. Each session consisted of 40 minutes of manual drainage of lymph nodes, performed by a trained therapist. Appropriate skin care methods were used, including moisturizing as well as using multi-layered short stretch bands. Baby oil was used as a lotion.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Yes - There is a plan to make this available</results_IPD_plan>
      <results_IPD_description>What will be shared:
After removing all variables related to identification of patients, the data would be shared. Patients has completed the consent from. data related to primary and secondary outcomes would be accessible.

When:
6 months after the publication of the first article in reputable journals, data will be available.

To whom:
The data will be provided to help researchers in their investigations as well as to inform patients about their condition

Conditions:
Researchers can use the data of this study in their studies to conduct new studies. It will also be provided to patients in order to be aware of their condition.

Where to obtain:
Roghayeh Mokhtari Hessari, PhD student in sports physiology
Phone: 09145884100
Email r.hesari 1353@gmail.com

How to obtain:
The request for data will be reviewed with the authors and contributors of the project and will be made available to others while maintaining ethical protocols.This process might take up to one month.

Comments:
</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Roghaye Mokhtari Hesari</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>No. 30, Saadi 6, Andisheh</address>
        <city>Miyane</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>5315948331</zip>
        <telephone>+98 41 5223 5720</telephone>
        <email>r.hesari1353@gmail.com</email>
        <affiliation>Islamic Azad University</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Roghaye Mokhtari Hesari</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>No. 30, Saadi 6, Andisheh</address>
        <city>Miyane</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>5315948331</zip>
        <telephone>+98 41 5223 5720</telephone>
        <email>r.hesari1353@gmail.com</email>
        <affiliation>Islamic Azad University</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Patients with unilateral lymphedema, stage II
Patients without history of using complete decongestive therapy
Having no regular exercise during the last six month
Menopausal women
No infection in the arm and no severe skin redness
Not taking anticoagulants
No nerve injuries in the upper extremity
No history of heart failure
No history of kidney disease
No paralysis in the hand or arm
No cancer recurrence</inclusion_criteria>
      <agemin>47 years</agemin>
      <agemax>65 years</agemax>
      <gender>Female</gender>
      <exclusion_criteria></exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>I89.0</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Lymphedema, not elsewhere classified</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Rehabilitation</i_code>
      <i_code>Treatment - Other</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group: The standard decongestant treatment method combined with selected pilates training was performed for 6 weeks and 5 days per week for 30-40 minutes. warm up exercises included 10 minutes of breathing exercises then the main movements were performed aiming at strengthening arm and shoulder muscles containing rest intervals, thus the exercises continued until fatigue which included 7 exercises in one to three sets for 20 minutes. At the end, stretching and body cooling exercises were performed for 5 minutes.</i_keyword>
      <i_keyword>Control group: Patients in the control group received standard combined decongestive therapy involves manual drainage of lymph nodes which was performed daily (5 days a week) for 3 weeks for a total of 21 sessions. Each session consisted of 40 minutes of manual drainage of lymph nodes, performed by a trained therapist. Appropriate skin care methods were used, including moisturizing as well as using multi-layered short stretch bands. Baby oil was used as a lotion.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Quality of life. Timepoint: Three times: before study, after interventions and one month after treatment and exercise. Method of measurement: Quality of life questionnaire; SF-36.</prim_outcome>
      <prim_outcome>The expression of CA-153. Timepoint: 48 hours before the intervention and at the end of the study. Method of measurement: ELISA Kit.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome>The edema volume. Timepoint: Three times: 48 hours before the intervention, at the end of the study and one month after the intervention. Method of measurement: Volumetric cylinder or volumetric tank or volumetric meter.</sec_outcome>
      <sec_outcome>Shoulder range of motion. Timepoint: Three times: 48 hours before the intervention, at the end of the study and one month after the intervention. Method of measurement: Goniometer.</sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Islamic Azad University</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2020-10-18</approval_date>
        <contact_name>Sport science Research Institute</contact_name>
        <contact_address>No. 3, 5th Alley, Miremad Street, Motahhari Street, Tehran, Iran. Tehran Tehran Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
